Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

J. L Jones, J. M Anderson, C. L Phuah, E. J Fox, K Selmaj, D Margolin, S. L Lake, J Palmer, S. J Thompson, A Wilkins, D. J Webber, D. A Compston and A. J. Coles

Brain 133 ( 8 ): 2232 - 2247 , 2010